Puma Biotechnology amends bylaws to align with universal proxy rules and enhance stockholder disclosure requirements

PUMA BIOTECHNOLOGY, INC.

Board adopted Fourth Amended and Restated Bylaws on August 17, 2023, effective immediately.
Amendments address universal proxy rules under Rule 14a-19, requiring compliance for non-board solicitations.
Non-board proxy solicitations must use a proxy card color other than white, reserved for Board use.
Enhanced advance notice disclosure for stockholders proposing business or nominating directors, including ownership and litigation info.
Technical updates to align with Delaware General Corporation Law and Exchange Act.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PUMA BIOTECHNOLOGY, INC.: Adopted amended and restated bylaws addressing universal proxy rules, proxy card color, advance notice disclosure, and other updates (effective 2023-08-17).

Change: bylaw amendment
Effective: 2023-08-17

Exact text from the filing

On August 17, 2023, the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Third Amended and Restated Bylaws (as so amended, the “Bylaws”).

View on SEC.gov

Browse all governance changes →

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-024168

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.